Morgan and Mendel Genomics Revenue and Competitors

Morgan and Mendel Genomics is a newly established medical and biotechnology device development company that intends to design, patent, and market affordable genetic testing devices in the human, animal and plant genetic and genomic testing niche markets. Four devices have been designed and are in the advanced development phase at a leading genetics research laboratory at New York’s Albert Einstein College of Medicine (Einstein). The founders are Dr. Harry Ostrer (Professor of Pathology and Pediatrics at Albert Einstein College of Medicine and Director of Genetic and Genomic Testing at Montefiore Medical Center) and Johnny Loke (Associate faculty, Department of Pathology, Albert Einstein College of Medicine) The mission of Morgan and Mendel Genomics is to commercialize FVA technology in the genetics and genomic research and clinical markets. The company will develop, manufacture and market FVA kits for research use and will provide contract research services. A number of kits are slated to become laboratory-developed tests (LDTs) for clinical use and, subsequently, Food and Drug Administration (FDA)-approved tests. Sales of each of these kits could readily top $50 million dollars annually. Each product is designed with simplicity and price point to appeal to the market for diagnosis, disease prevention, response to therapy and toxicities management. The company is currently looking to recruit the following positions: None at this time